Synonym
Cicloprofen; (±)-Cicloprofen; (±) Cicloprofen; α-Methylfluorene-2-acetic Acid; NSC 293916; NSC293916; NSC-293916; SQ 20,824; SQ20,824; SQ-20,824;
IUPAC/Chemical Name
2-(9H-fluoren-2-yl)propanoic acid
InChi Key
LRXFKKPEBXIPMW-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H14O2/c1-10(16(17)18)11-6-7-15-13(8-11)9-12-4-2-3-5-14(12)15/h2-8,10H,9H2,1H3,(H,17,18)
SMILES Code
O=C(O)C(C1=CC=C2C3=C(C=CC=C3)CC2=C1)C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| Ethanol |
20.0 |
83.93 |
|
| DMSO |
30.0 |
125.90 |
|
| DMF |
30.0 |
125.90 |
|
| DMSO:PBS (pH 7.2) (1:3) |
0.3 |
1.05 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
238.29
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Giuglio-Tonolo AG, Terme T, Vanelle P. Original Synthesis of Fluorenyl Alcohol Derivatives by Reductive Dehalogenation Initiated by TDAE. Molecules. 2016 Oct 24;21(10):1408. doi: 10.3390/molecules21101408. PMID: 27783046; PMCID: PMC6274501.
2: Rocco A, Maruška A, Fanali S. Cyclodextrins as a chiral mobile phase additive in nano-liquid chromatography: comparison of reversed-phase silica monolithic and particulate capillary columns. Anal Bioanal Chem. 2012 Mar;402(9):2935-43. doi: 10.1007/s00216-012-5764-6. Epub 2012 Feb 16. PMID: 22349325.
3: Knights KM, Winner LK, Elliot DJ, Bowalgaha K, Miners JO. Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP- glucuronosyltransferases: inhibition by NSAIDs. Br J Clin Pharmacol. 2009 Sep;68(3):402-12. doi: 10.1111/j.1365-2125.2009.03469.x. PMID: 19740398; PMCID: PMC2766480.
4: Rocco A, Fanali S. Enantiomeric separation of acidic compounds by nano-liquid chromatography with methylated-beta-cyclodextrin as a mobile phase additive. J Sep Sci. 2009 May;32(10):1696-703. doi: 10.1002/jssc.200800667. PMID: 19370733.
5: Aishah AJ, Nobuhito K, Tokuda M. Synthesis of precursor of anti-inflammatory agents by using highly reactive zinc. Med J Malaysia. 2004 May;59 Suppl B:210-1. PMID: 15468892.
6: Roberts BJ, Knights KM. Inhibition of rat peroxisomal palmitoyl-CoA ligase by xenobiotic carboxylic acids. Biochem Pharmacol. 1992 Jul 22;44(2):261-7. doi: 10.1016/0006-2952(92)90008-7. PMID: 1386510.
7: Singh NN, Pasutto FM, Coutts RT, Jamali F. Gas chromatographic separation of optically active anti-inflammatory 2-arylpropionic acids using (+)- or (-)-amphetamine as derivatizing reagent. J Chromatogr. 1986 May 28;378(1):125-35. doi: 10.1016/s0378-4347(00)80705-7. PMID: 3733965.
8: Hutt AJ, Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids --a novel route with pharmacological consequences. J Pharm Pharmacol. 1983 Nov;35(11):693-704. doi: 10.1111/j.2042-7158.1983.tb02874.x. PMID: 6139449.
9: Hearn T, Wojnar RJ. Characterization of augmentation of allergic and non- allergic histamine release by non-steroidal anti-inflammatory/analgesic agents. Agents Actions. 1981 Jul;11(4):352-60. doi: 10.1007/BF01982471. PMID: 6169264.
10: Wojnar RJ, Hearn T, Starkweather S. Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory-analgesic agents. J Allergy Clin Immunol. 1980 Jul;66(1):37-45. doi: 10.1016/0091-6749(80)90136-0. PMID: 6155392.
11: Lan SJ, Dean AV, Kripalani KJ, Cohen AI. Metabolism of alpha- methylfluorene-2-acetic acid (cicloprofen): isolation and identification of metabolites from rat urine. Xenobiotica. 1978 Feb;8(2):121-31. doi: 10.3109/00498257809060391. PMID: 626004.
12: Dean AV, Lan SJ, Kripalani KJ, Difazio LT, Schreiber EC. Metabolism of the (+)-, (+/-)-, and (-)-enantiomers of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats. Xenobiotica. 1977 Sep;7(9):549-60. doi: 10.3109/00498257709038690. PMID: 602253.
13: Lan SJ, Kripalani KJ, Dean AV, Egli P, Difazio LT, Schreiber EC. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys. Drug Metab Dispos. 1976 Jul-Aug;4(4):330-9. PMID: 8287.
